Three Russian Prototypes of COVID-19 Vaccine Prove Effective

06 July 2020

GMP News

Three Russian prototypes of the vaccine against COVID-19 have demonstrated their efficacy in a series of tests, Rinat Maksiutov, Director General of the State Research Center for Virology and Biotechnology “Vector”, said in an interview to RIA Novosti.

At present, three prototypes of the vaccine against covid-19 have been successfully tested and proved capable of inducing immune response. These are the most advanced drugs in terms of efficacy,” he said.

At present, a total of 100 researchers from Vector are working on vaccines, Maksiutov pointed out. He added that the most important task was to design a vaccine offering the best possible protection against the disease. “The biggest challenge is to create a vaccine that is both potent and safe,” Vector’s Director-General said.

If the vaccine performs well on the safety and efficacy tests, Vector will launch clinical trials on July 15. The trials will be attended by 300 volunteers, Maksiutov said.

Source

Print

Shareholders

Read more

Pipeline

Read more

Media Center

Read more